Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»New “Cancer Flashlight” Could Reveal Who Truly Benefits From Targeted Treatments
    Health

    New “Cancer Flashlight” Could Reveal Who Truly Benefits From Targeted Treatments

    By University of Missouri-ColumbiaJanuary 14, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Cancer Cell Biology Illustration
    A new imaging strategy may help doctors quickly identify tumors suited for targeted cancer treatments. Credit: Stock

    A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to respond to targeted therapies.

    To better understand which patients may respond to targeted cancer therapies, a University of Missouri researcher is developing a new way to make tumors visible at the molecular level.

    In a recent study, Barry Edwards, an associate professor of biochemistry in the School of Medicine, engineered a very small antibody that is able to recognize and bind to EphA2, a protein frequently present in cancerous tumors. The antibody was then linked to a radioactive marker, making it detectable during a positron emission tomography (PET) scan.

    Tests in mice showed that this cancer-detecting “flashlight” produced a strong signal in tumors that contained EphA2. The findings suggest that this labeled antibody could be used not only to locate cancer, but also to help determine which patients are most likely to benefit from new treatments that specifically target EphA2-positive tumor cells while leaving healthy tissue unharmed.

    Barry Edwards
    Barry Edwards. Credit: University of Missouri

    Identifying the Right Patients for the Right Treatments

    “By finding out which patients have high or low amounts of EphA2, we can determine who is most likely to benefit from a targeted cancer treatment,” Edwards, who also has an appointment in the College of Arts and Science, said. “There is no sense in giving a treatment that won’t work to a patient, so this new process we created saves time and money while advancing precision medicine.”

    Currently, physicians rely on biopsies and MRIs to assess tumors in cancer patients, but these techniques can be invasive, time-consuming, and limited in the information they provide about specific proteins within cancer cells. Edwards — who uses state-of-the-art imaging equipment at Mizzou’s Molecular Imaging and Theranostics Center for his research — hopes to move this innovation from preclinical models to human clinical trials within seven years to provide a better method.

    “This new targeted approach is noninvasive, and you can get results from the imaging in hours rather than days, which can be huge for patients traveling long distances to seek treatment,” Edwards said. “By making the process easier and faster for both patients and clinicians, we’re showing that precision medicine is a win-win.”

    Reference: “Preclinical Evaluation of an Anti-EphA2 Minibody-Based ImmunoPET Agent as a Diagnostic Tool For Cancer” by Peggy A. Birikorang, H. E. G. Wedaarachchi, Jordan A. Smith, Gary Kohanbash and W. Barry Edwards, 19 September 2025, Molecular Imaging and Biology.
    DOI: 10.1007/s11307-025-02048-7

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Cancer Molecular Biology Oncology University of Missouri-Columbia
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Why Pancreatic Cancer Is So Deadly: New Study Reveals Hidden Invasion Pathway

    Vitamin A’s Dark Side: How a Common Nutrient Can Help Tumors Evade the Immune System

    Scientists Discover Hidden Link Between Two Hallmarks of Cancer

    Scientists Solve a Decade-Old Mystery Behind Cancer’s Most Violent DNA Chaos

    New Discovery Exposes the Hidden Weak Spot Cancer Uses to Survive DNA Damage

    Scientists Uncover New Weak Spot in Prostate Cancer Cells, a Game-Changer for Treatment

    A New Way To Stop Cancer Growth: Groundbreaking Drug Enters Human Trials

    A Universal Weak Spot? Scientists Solve Decades-Old Cancer Mystery

    Researchers Find a New Target to Treat a Wide Spectrum of Cancers

    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Scientists Discover Two Monster Black Holes at the Dawn of Time That Shouldn’t Exist

    Not All Physical Activity Protects Your Brain, Scientists Warn

    Rewriting History: New Research Reveals Ancient Iron Age King May Have Been a Woman

    A Strange Black Hole Gap Could Reveal Stars That Died Without Exploding

    A Deadly Blood Cancer May Begin More Than 50 Years Before Symptoms Appear

    Scientists Discover a Giant 66-Pound Rodent That Lived 34 Million Years Ago

    Scientists Unlock a New Way To Photograph Events That Vanish in Trillionths of a Second

    Why Do We Feel Colder As We Get Older? New Study Uncovers a Hidden Mechanism

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • A Common Heart Failure Warning Sign May Actually Be Causing Dangerous Blood Clots
    • Scientists Uncover Why a Common Nutrient Can Be Dangerous for Blood Vessels
    • Scientists Discover That Producing Light More Slowly Could Improve Future Quantum Networks
    • A New Light-Powered Quantum Processor Could Overcome a Major Computing Barrier
    • Mysterious Radio Signals From 5,000 Light-Years Away Lead Scientists to a Surprising Discovery
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.